A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation

PHASE2TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

September 30, 2015

Conditions
Parkinson's Disease
Interventions
DRUG

RM-131

DRUG

Placebo

Trial Locations (13)

Unknown

University of Southern California, Los Angeles

Colorado Neurological Institute, Englewood

University of Florida Ctr for Movement Disorders & Neurorestoration, Gainesville

Emory University, Wesley Woods Health Center, Atlanta

Georgia Regents University, Augusta

University of Iowa Hospitals, Movement Disorders Div, Dept of Neurology, Iowa City

Michigan State University, East Lansing

Henry Ford West Bloomfield Hospital, West Bloomfield

Atlantic Neuroscience, Summit

University of Rochester, Rochester

University of Toledo Medical Center, Toledo

Movement Disorders Program & The Parkinson's Center of Oregon, Portland

University of Pennsylvania, Penn Neurological Institute, Philadelphia

Sponsors
All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

Motus Therapeutics, Inc.

INDUSTRY

NCT01955616 - A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation | Biotech Hunter | Biotech Hunter